Literature DB >> 7794920

Structure-activity analysis of a Conus peptide blocker of N-type neuronal calcium channels.

L Nadasdi1, D Yamashiro, D Chung, K Tarczy-Hornoch, P Adriaenssens, J Ramachandran.   

Abstract

The synthetic peptide SNX-111 corresponding to the sequence of the omega-conopeptide MVIIA from the venom of the marine snail Conus magus is a highly potent and selective antagonist of N-type calcium channels. We have synthesized and characterized a large number of analogs of SNX-111 in order to elucidate the structural features of the peptide involved in blocking N-type calcium channels. Comparison of the binding of SNX-111 and its analogs to rat brain synaptosomal membranes rich in N-type channels revealed that, among the four lysines and two arginines in the molecule, lysine in position 2 and arginines at position 10 and 21 are important for the interaction of SNX-111 with N-type channels. The importance of the middle segment from residues 9 through 14 for this binding interaction was revealed by substitution of the individual residues as well as by the construction of hybrid peptides in which the residues 9-12 in SNX-111 and another conopeptide, SNX-183, corresponding to a peptide SVIB from Conus striatus, were interchanged. Introduction of the sequence SRLM from SNX-111 in place of RKTS in position 9-12 in SNX-183 resulted in a 38-fold increase in affinity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794920     DOI: 10.1021/bi00025a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Solution structure and backbone dynamics of an omega-conotoxin precursor.

Authors:  D P Goldenberg; R E Koehn; D E Gilbert; G Wagner
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

2.  Ih channels as modulators of presynaptic terminal function: ZD7288 increases NMDA-evoked [3H]-noradrenaline release in rat neocortex slices.

Authors:  Maximilian Klar; Rainer Surges; Thomas J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-13       Impact factor: 3.000

Review 3.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 4.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 5.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

6.  Ziconotide.

Authors:  Katherine A Lyseng-Williamson; Caroline Perry
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA.

Authors:  Maciej Gasior; Natalie A White; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2007-08-23       Impact factor: 4.030

Review 8.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Asteropsin A: an unusual cystine-crosslinked peptide from porifera enhances neuronal Ca2+ influx.

Authors:  Huayue Li; John J Bowling; Frank R Fronczek; Jongki Hong; Sairam V Jabba; Thomas F Murray; Nam-Chul Ha; Mark T Hamann; Jee H Jung
Journal:  Biochim Biophys Acta       Date:  2013-03

10.  Development of small molecules that mimic the binding of omega-conotoxins at the N-type voltage-gated calcium channel.

Authors:  Christina I Schroeder; Mark L Smythe; Richard J Lewis
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.